JOEL SAGET/AFP/Getty Images
Just one week after Pfizer announced its COVID-19 vaccine was 90% effective, U.S. pharmaceutical company Moderna has said that its vaccine in late-stage trials is 94.5% effective in preventing coronavirus. Happy vaccine month!
Moderna's trial tested 30,000 subjects; some got the vaccine, others a placebo. Science reports that only five people with the vaccine contracted COVID-19, while 90 people in the placebo group got it, meaning it's nearly 95% effective.